Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 1,055 | 703 | -517 | 474 | 896 |
| Operating Income | -1,055 | -703 | 517 | -474 | -896 |
| Interest Expense | 89 | 89 | 116 | 103 | 72 |
| Other Income | -4 | 9 | -157 | 127 | 6 |
| Pre-tax Income | -1,149 | -783 | 244 | -451 | -962 |
| Net Income Continuous | -1,149 | -783 | 244 | -451 | -962 |
| Net Income | $-1,149 | $-783 | $244 | $-451 | $-962 |
| EPS Basic Total Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.02 |
| EBITDA(a) | $-1,060 | $-695 | $360 | $-348 | $-890 |